This month on Synapse
Alex Walker explains what block chain technology is and how the life sciences and healthcare industries stand to benefit from it.
Topical issues
Raman Sharma, Rhys Bufton and Lucy Sharples discuss how to choose among the various letting strategies available in the life sciences space.
The General Court has upheld a decision of the Board of Appeal that the marks Normon and Normosang, both covering pharmaceutical products, are confusingly similar.
Paul England brings news of the latest SPC development, the Ag's Opinion on whether or not Truvada (a combination of tenofovir disoproxil and emtricitabine) is protected by a patent claiming tenofovir disoproxil and ̔optionally other therapeutic ingredients.
After delay, the UK has ratified the UPC Agreement. What next?
